To determine if IL4I1-associated AKA levels were also altered in people with MS, we compared the serum levels of PPA and HPPA, as well as the ratios of PPA or HPPA to the aromatic amino acids from which they are derived, between people with MS and HCs. This evidence concerns the gene IL4I1 and myeloid sarcoma.